Cytoskeleton

The chondrocyte cytoskeleton, and the actin network in particular, is now recognised as a central controller of the cell's differentiated state rather than a passive scaffold [1]. Stimuli such as serial passaging, pro-inflammatory cytokines and osteoarthritis converge on the RhoA/ROCK/Rac1 axis to drive actin polymerisation and stress-fibre formation [1]. Because stress-fibre formation and phosphorylation of the master chondrogenic factor SOX9 are both ROCK-activity dependent, the balance between actin polymerisation and depolymerisation effectively sets the chondrocyte phenotype [1]. Reorganisation of the actin cytoskeleton is by itself sufficient to push chondrocytes toward dedifferentiation, acting through PI3-kinase/Akt and p38 mitogen-activated protein kinase signalling [2]. The stiffness of the surrounding matrix feeds into the same machinery, remodelling the F-actin cytoskeleton and altering SOX9 activity and collagen output [4].

Cytoskeletal state is also coupled to the primary cilium: as chondrocytes expand and form actin stress fibres, they lose cilia and the hedgehog signalling that depends on them, further entrenching the dedifferentiated phenotype [3]. Together these findings position actin dynamics as a decisive, and pharmacologically addressable, lever over cartilage-cell behaviour [1]. Modulating the polymerisation and depolymerisation balance is therefore an emerging strategy for holding chondrocytes in, or returning them to, their functional state [4]. This cytoskeletal control of chondrocyte identity is precisely the axis Jessica's thesis interrogates at single-cell resolution [1].